We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Bod Australia Limited is a household & personal products business based in Australia. Bod Australia shares (BDA) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Bod Australia has a trailing 12-month revenue of around $7.4 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Cheap broker fees
| 52-week range | $0.2525 - $0.74 |
|---|---|
| 50-day moving average | $0.2943 |
| 200-day moving average | $0.3791 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.043 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.315
| 1 week (2021-09-21) | 21.15% |
|---|---|
| 1 month (2021-08-27) | 8.62% |
| 3 months (2021-06-28) | -8.70% |
| 6 months (2021-03-26) | -37.00% |
| 1 year (2020-09-28) | -20.25% |
|---|---|
| 2 years (2019-09-27) | -30.77% |
| 3 years (2018-09-28) | -47.50% |
| Revenue TTM | $7.4 million |
|---|---|
| Gross profit TTM | $3.5 million |
| Return on assets TTM | -28.11% |
| Return on equity TTM | -62.76% |
| Profit margin | -56.96% |
| Book value | 0.082 |
| Market capitalisation | $32.8 million |
TTM: trailing 12 months
We're not expecting Bod Australia to pay a dividend over the next 12 months.
Over the last 12 months, Bod Australia's shares have ranged in value from as little as $0.2525 up to $0.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Bod Australia's is 1.1122. This would suggest that Bod Australia's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Bod Australia Limited operates as a cannabidiol and medical cannabis healthcare company in Australia, the United Kingdom, the European Union, and the United States. The company operates through three segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, and OTC Herbals. It engages in the development and manufacture of cannabidiol and hemp products for consumers; and development, manufacture, and distribution of therapeutics medicinal cannabis products for medical markets. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long-term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
We look at some of the biggest and best performing iron ore stocks in Australia.
Shares in the major banks have risen more than 50% in the last 12 months.
Steps to owning and managing China Evergrande Group shares from Australia.
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
